Mayo Clinic identifies new risk factor for heart attack patients

“This research should emphasize to patients that getting help immediately, by calling 911, gives them the best chance of receiving treatments we know can help save their lives or lessen the damage to their hearts,” says Henry Ting, M.D., lead Mayo Clinic cardiovascular researcher on the national study. “If patients wait at home for hours with symptoms and come in later, unfortunately they aren’t getting the proper treatments.”

The most serious type of heart attack is known as an ST-elevation myocardial infarction (STEMI). In a STEMI, critical arteries supplying the heart with blood are blocked. Previous studies have shown that the best treatment for STEMI patients is reperfusion therapy -- when a patient’s blocked artery is opened by inflating a balloon at the site of the blockage or by delivering clot-dissolving medication, thus restoring blood flow to heart muscle.

The study is the largest and most detailed review of multiple elements in patient records contained in a national heart attack database. These elements are: time delay from onset of symptoms to hospital arrival; treatment with reperfusion; and treatment outcome. After analyzing 440,398 heart attack incidents from 1995 to 2004 in the National Registry of Myocardial Infarction, the researchers identify for the first time a novel risk factor for heart attack deaths that appears to have a readily available solution: comply with the American Heart Association/American Cardiology Association guidelines now in place. The guidelines state that if a patient has symptoms consistent with a heart attack which are not relieved after five minutes, or after placing one nitroglycerin pill under the tongue, the patient should call 911.

The records that the team reviewed document how long it took for 440,398 heart attack patients to arrive at the hospital after their symptoms started, and correlate arrival time with the rates of reperfusion therapy they received upon arriving at the hospital.

Results show that:

-- Of patients who arrived at the hospital within one to two hours of onset of heart attack, 77 percent received reperfusion therapy.

-- Of patients who arrived at the hospital within two to three hours of onset of heart attack, 73 percent received reperfusion therapy.

-- Of patients who arrived at the hospital within 11 to 12 hours of onset of heart attack, only 46 percent of patients received reperfusion therapy.

“Although current guidelines recommend that STEMI patients who reach the hospital within 12 hours after their symptoms started should receive reperfusion therapy, we found that this is not happening,” Dr. Ting says. “These delays represent a novel and modifiable risk factor and warrant further investigation. These results show that gaps remain in quality of care in patients with STEMI -- first, we need to encourage patients with potential heart attacks to come to the hospital as early as possible; second, hospitals need to implement systems that treat all eligible patients rapidly regardless of the delay in presentation.”

Source: Mayo Clinic

At risk for peripheral arterial disease? Simple quiz provides key so you can circulate better
Ten million Americans have peripheral arterial disease (PAD), and research shows that the highest risk populations include African-Americans (twice as likely to develop clogged leg arteries), seniors (12-20 percent develop PAD) and diabetics (one in three who are over the age of 50 develop PAD). Legs for Life®—a community health and public information program—recommends that older Americans take its free, online self-assessment quiz.
Smoking riskier to women's hearts than men's
(AP) -- Women typically get heart disease much later than men, but not if they smoke, researchers said Tuesday. In fact, women who smoke have heart attacks nearly 14 years earlier than women who don't smoke, Norwegian doctors reported in a study presented to the European Society of Cardiology. For men, the gap is not so dramatic; male smokers have heart attacks about six years earlier than men who don't smoke.
Pfizer resuming ads for Lipitor after controversy
(AP) -- Television ads for the world's top-selling drug, cholesterol fighter Lipitor, are back, six months after Pfizer Inc. pulled them amid charges its use of a celebrity doctor endorser who's never practiced medicine misled the public. This time, Pfizer is leaving out the celebrity.
Value of direct-to-consumer drug advertising oversold, study finds
Direct-to-consumer advertising may not be giving big pharma such a big bang for their buck after all. Despite the billions spent on bringing drug marketing campaigns straight into patients' living rooms, such strategies have a modest effect at best—and in some cases, no effect at all.
Global study shows telmisartan reduces outcome of cardiovascular death, heart attack or stroke
An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and effective standard treatment.
Treadmill exercise retrains brain and body of stroke victims
People who walk on a treadmill even years after stroke damage can significantly improve their health and mobility, changes that reflect actual "rewiring" of their brains, according to research spearheaded at Johns Hopkins.
Risk of repeat attacks in heart patients causes concern for doctors
An international study, led by the University of Edinburgh, raises concerns that some patients may not be receiving the optimum medical treatment and follow-up care because doctors are misjudging the risk of a further heart attack.
Heart attack patients who stop statin risk death, say researchers
Patients discontinuing statin medication following an acute myocardial infarction (AMI) increase their risk of dying over the next year, say researchers at McGill University and the McGill University Health Centre (MUHC). Their study was published in a recent issue of the European Heart Journal.

Mayo Clinic identifies new risk factor for heart attack patients

Related stories:

News discussion: